Lannett: FDA Approves Manufacture Of Numbrino At Its Main Plant In Seymour, Indiana
businessinsider.com
finance
2022-10-21 13:53:04

(RTTNews) - Generic pharmaceutical products maker Lannett Co., Inc. (LCI) announced Friday that it has received approval from the US Food and Drug Administration to manufacture its branded topical anesthetic product, Numbrino, at its main plant in Seymour, Indiana. In pre-market activity on the NYSE, Lannett shares were gaining around 9.7 percent to trade at $0.44. The company previously manufactured Numbrino and other liquid drug products at its Carmel, New York plant, which was sold in March as part of a restructuring and cost reduction plan.
